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Abstract
Chlorella virus NY-2A has a large, highly methylated dsDNA genome (45% of the cytosines are 5-methylcytosine and 37% of
the adenines are N6-methyladenine). Here, we report the cloning, expression, and characterization of the NY-2A-encoded CviQII
nicking-modification (N-M) system. The nicking endonuclease, Nt.CviQII, recognizes R ↓ AG (R = A or G, ↓ indicating cleavage
site) sequences and cleaves the phosphodiester bond 5′ to the adenosine. Because of the difficulty in cloning and expressing the
wild-type Nt.CviQII, C-terminal truncation mutants were generated and full-length Nt.CviQII was reconstructed by intein-mediated peptide ligation. The truncation mutants and the reconstructed full-length Nt.CviQII have the same recognition and cleavage specificity as the native enzyme. Full-length and truncated Nt.CviQII produced by a cell-free transcription/translation system
have similar reaction rates. The methyltransferase, M.CviQII, was also cloned and expressed. It modifies the adenine in AG doublets of DNA in vitro and in vivo in Escherichia coli. To our knowledge, M.CviQII is the first adenine methyltransferase that recognizes a dinucleotide. Therefore, M.CviQII may be a useful reagent for blocking endonuclease cleavage when restriction sites overlap with AG sequences.
Keywords: Chlorella virus, intein-mediated peptide ligation, methyltransferases, nicking endonucleases, restriction-modification
system
Abbreviations: AdoMet, S-adenosyl-methionine; BAC, bacteria artificial chromosome; CBD, chitin-binding domain; ds, doublestrand; m5C, 5-methylcytosine; m6A, 6-methyladenine; MTase, methyltransferase; NEase, nicking endonuclease; N-M, nickingmodification system; Nt, top-strand nicking; REase, restriction endonuclease; R-M, restriction-modification; ss, single-strand; wt,
wild-type.

The chlorella viruses are large, icosahedral, plaqueforming, genetically diverse but morphologically similar
viruses. They have linear dsDNA genomes (315–380 kb)
and belong to the family Phycodnaviridae, genus Chlorovirus [1]. The prototype chlorella virus, Paramecium bursaria
chlorella virus (PBCV-1) has a 331-kb genome that contains ~366 protein-encoding genes of 65 or more codons
and a polycistronic tRNA operon encoding 11 tRNAs.
The chloroviruses infect certain fresh water, unicellular,
eukaryotic chlorella-like green algae, which normally exist as endosymbionts in the protozoan P. bursaria.
One distinctive feature of the chlorella viruses is that
they contain genes encoding Type II DNA site-specific
restriction endonucleases (REases) and their companion

DNA methyltransferases (MTases), collectively referred
to as restriction-modification (R-M) systems. REases recognize and cleave specific nucleotide sequences, while
their companion DNA MTases protect DNA from cleavage by methylating one of the nucleotides in the same
nucleotide sequence. The number of MTase genes varies
from virus to virus. For example PBCV-1 has five MTaseencoding genes, two of which have companion REases,
whereas virus NY-2A has at least 10 functional MTase-encoding genes [2]. As a result, the NY-2A genome is heavily methylated and its genomic DNA is resistant to many
REases [3].
Two virus-encoded site-specific DNA endonucleases have been isolated from NY-2A infected chlorella
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cells. R.CviQI creates double-strand breaks 5′ to the T in
the palindromic sequence G ↓ TAC [4] and NY-2A nickase makes single-strand breaks 5′ of the A in R ↓ AG sequences [2]. The NY-2A nickase, later named Nt.CviQII,
is interesting because it recognizes three bases with 2-fold
degeneracy in the first base, the shortest recognition sequence among all known dsDNA cleaving and nicking
endonucleases (NEase). Its companion MTase should
also recognize RAG or shorter sequences. Only one other
three-base NEase has been described: Nt.CviPII encoded
by chlorella virus NYs-1 [5, 6]. Nt.CviPII recognizes ↓CCD
sequences (D = A, G, or T; three bases with 3-fold degeneracy in the third base). Therefore, cloning and characterizing Nt.CviQII and its companion MTase M.CviQII
should provide additional information on NEases that
recognize and cleave DNA frequently. Here, we report
expression and purification of C-terminal deletion variants of Nt.CviQII and reconstruction of the full-length enzyme by intein-mediated peptide ligation. Recombinant
M.CviQII was also purified and its recognition sequence
was found to be more degenerate than that of the cognate
NEase.
Materials and Methods
Identification of the CviQII N-M genes
Genomic DNA from virus NY-2A was isolated from
purified virions as described [3]. The methyltransferase selection method [7] was used to clone the cviQIIM
gene. NY-2A genomic DNA was partially digested with
2-fold serial dilutions of Sau3AI and ligated into BamHIdigested and calf intestinal alkaline phosphatase (CIP)treated pUCAC (a derivative of pUC19 containing a
chloramphenicol-resistant gene [6]). The ligated products
were transformed into Escherichia coli ER1992 [Δ(argFlac)U169 glnV44 mcr-67 rfbD1? relA1? endA1 dinD2::
MudI1734 (KmR, lacZ+) spoT1? thi-1 Δ(mcrC-mrr)114::IS10].
Clones that expressed M.CviQII were selected by digesting plasmid DNA from the transformed cells with MnlI
[CCTC(N7)↓; complementary sequence ↓(N6)GAGG, ↓
indicating cleavage site] at 37 °C for 2 h. MnlI does not
cleave GmAGG sequences and so MnlI-resistant plasmids
should be expressing M.CviQII. The MnlI-treated plasmid library was used to transform E. coli ER2502 [fhuA2
ara-14 leu Δ(gpt-proA)62 lacY1 glnV44 galK2 rpsL20 endA1
R(zgb210::Tn10)TcSxyl-5 mtl-1 Δ(mcrC-mrr)HB101]. Clones
partially resistant to MnlI were selected, which could contain the cviQIIM gene. Inserts from the plasmids were sequenced using pUC universal forward and reverse primers as well as custom-designed primers. The sequences
were subjected to a BLAST search against REBASE and
GenBank [8, 9].
Genes encoding R-M systems are located adjacent to
one another in most cases [REBASE, [8]]. Therefore, DNA
flanking the cviQIIM gene was sequenced from the NY-2A
genomic DNA using custom primers to look for cviQIINt.

Expression and purification of M.CviQII
The cviQIIM gene was amplified from NY-2A genomic
DNA by PCR such that NdeI and SapI sites were added
to the 5′ and 3′ ends of the gene, respectively. The amplified DNA was inserted into pTXB1 at NdeI and SapI sites
so that M.CviQII was expressed as a fusion protein with a
Mxe GyrA intein and chitin-binding domain (CBD) at its
C-terminus [10]. E. coli ER2566 [fhuA2 lacZ::T7 gene1 [lon]
ompT gal sulA11 [dcm] R(zgb-210::Tn10–TcS) endA1 Δ(mcrCmrr)114::IS10 R(mcr-73::miniTn10–TcS)2] was transformed
by the plasmid and expression was induced with 0.25 mM
IPTG for 3 h at 37 °C. Cells were harvested, re-suspended
in 20 mM sodium phosphate buffer, pH 6.5, sonicated on
ice and the disrupted cells were centrifuged at 12,000g for
20 min at 4 °C. The fusion protein appeared as an inclusion body. The pellet was washed with 0.2 M NaCl, 1% deoxycholate and then with 1% Triton X-100, 1 mM EDTA.
The washed inclusion bodies were solubilized in 25 ml of
6.5 M guanidine hydrochloride (GdnHCl), 50 mM Tris,
0.5 M NaCl, pH 8.0, and incubated at room temperature
for 2 h. The solubilized protein was clarified by centrifugation (12,000g for 20 min at 4 °C) and added dropwise to
a refolding buffer [55 mM MES (2-Morpholinoethanesulfonic acid), pH 6.5, 0.56 mM NaCl, 0.44 mM KCl, 1.1 mM
EDTA, 1 mM DTT, 440 mM sucrose, 550 mM l-arginine,
final pH 10.6 at 25 °C] with constant stirring at room
temperature (FoldIt Screen protein refolding kit, Hampton Research). The solution containing the refolded protein was incubated at room temperature for 2 h and then
with 50 mM DTT for 5 h to induce cleavage of the intein.
The solution turned turbid after 2 h; however, SDS–PAGE
analysis indicated that most of the cleaved M.CviQII protein remained in the soluble fraction. The soluble protein
was dialyzed against 20 mM sodium phosphate buffer,
0.1 M NaCl, pH 6.5 at 4 °C and cleared by centrifugation.
Refolded protein was loaded on an SP column (15 ml bed
volume; Amersham) and eluted using a 0.1–1.0 M NaCl
gradient; M.CviQII eluted at ~0.3 M NaCl. Fractions containing M.CviQII were pooled, concentrated, and stored
in 50% glycerol (v/v) at −20 °C. Protein concentrations
were determined by the Bradford method.
Cell-free transcription/translation of Nt.CviQII and its truncation mutants
Cell-free transcription/translation of Nt.CviQII was
accomplished with the Pure System™ classic II kit (Post
Genome Institute Co. Ltd., Tokyo, Japan). Oligonucleotides were designed to generate both full-length and
truncation mutants of Nt.CviQII by PCR. Two-step PCR
was used to incorporate a T7 promoter and ribosomebinding sequence at the 5′ end of the genes following the
manufacturer’s instructions. The PCR products were gelpurified and used as templates for in vitro transcription/
translation according to the manufacturer’s instructions.
Aliquots of the translation reactions were used directly in
DNA nicking assays.
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Nt.CviQII truncation mutants and intein-mediated peptide
ligation
C-terminal truncation mutants of Nt.CviQII, NQN509,
and NQN528, which have deletions of 41 and 22 amino
acids, respectively, were amplified from NY-2A genomic DNA by PCR. Ser509 of NQN509 and Ser528 of
NQN528 were mutated to Cys residues to facilitate intein-mediated peptide ligation. Primers were used to
add NdeI and SapI restriction sites to the 5′ and 3′ ends
of the PCR products, respectively. The PCR products
were inserted into pTXB1 by the same method used to
clone cviQIIM. After verifying the DNA sequence, the
constructs were transformed into E. coli ER2566 for expression. Expression procedures were identical to those
used for M.CviQII. Cells were harvested, re-suspended
in chitin column buffer (20 mM Tris–HCl, 0.5 M NaCl,
0.1% Triton X-100, 1 mM EDTA, pH 8.0), sonicated and
centrifuged. Both truncated fusion proteins were soluble and they were applied to a chitin column (20 ml bed
volume). After washing the column using chitin column
buffer, the fusion proteins were released by incubating
the bound protein with 50 mM sodium 2-mercaptoethanesulfonate (MESNA) overnight at 4 °C; the released
proteins were eluted from the column with two-bed volumes of chitin column buffer.
The truncated proteins were ligated to C-terminal peptides as follows: 0.01 μmol of protein (0.7 mg) from the
chitin column fractions was incubated with 1 μmol of peptide in 1 ml of chitin column buffer with 50 mM MESNA
at 4 °C or 25 °C overnight. The ligated proteins were purified through a heparin column (Amersham; 10 ml bed
volume) using a NaCl gradient in 20 mM Tris–HCl, pH
7.9. The peptides were synthesized in-house at New England Biolabs (NEB).
The NQN509 protein was subjected to additional purification. Fractions containing NQN509 that eluted
from the chitin column were diluted 4-fold with 20 mM
Tris–HCl, pH 7.8 such that the NaCl concentration was
125 mM. The diluted protein solution was applied to a
Heparin HyperD M column (BioSepra, 30 ml bed volume), which was then eluted with a linear NaCl gradient [50 mM—1 M]. Fractions containing the truncated
protein were pooled and dialyzed against 10 mM potassium phosphate buffer, 50 mM NaCl, 1 mM EDTA, pH
7.0, and applied to a hydroxyapatite column (Bio-Rad
Bio-gel HTP; 15 ml bed volume). Proteins were eluted
using a linear gradient of 10–500 mM potassium phosphate buffer. Peak fractions were assayed using pBR322
DNA as a substrate, pooled, concentrated, and stored in
20 mM Tris–HCl, 100 mM NaCl, pH 8.0, and 50% glycerol at −20 °C.
In vivo and in vitro M.CviQII MTase activity
Total DNA was isolated from pUCAC-cviQIIM-transformed ER2502 to measure M.CviQII MTase activity in
vivo. One microgram of total DNA was incubated with
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10–20 U of selected REases at 37 °C for 1 h in appropriate buffer conditions as suggested by the manufacturer
(NEB). The DNA fragments were analyzed by electrophoresis on 0.8% agarose gels.
To test in vitro activity, 1 μg of pUC19 was incubated
with 2 μg of M.CviQII and 80 μM of S-adenosyl-methionine (AdoMet) in NEB buffer 2 (10 mM Tris–HCl, 10 mM
MgCl2, 50 mM NaCl, 1 mM DTT, pH 7.9) at 37 °C for
1 h in 20 μl reactions. After heat-inactivation at 65 °C for
15 min, the reaction volume was increased to 50 μl in the
appropriate buffers (NEB) and incubated with 10–20 U of
selected REases at 37 °C for 1 h.
DNA nicking activity assay
DNA nicking activity of the truncated and ligated
Nt.CviQII proteins were assayed using pBR322 or pUC19
DNA as substrates. Various amounts of protein were incubated with 1 μg of DNA in NEB buffer 2 (10 mM Tris–
HCl, 10 mM MgCl2, 50 mM NaCl, 1 mM DTT, pH 7.9) at
specific temperatures for various times. Cleaved DNA
products were analyzed by electrophoresis on 1.5% agarose gels. To determine the cleavage specificity of the
Nt.CviQII truncation mutants, DNA cleavage fragments
were filled-in using Klenow fragment in the presence of
33 μmol dNTPs according to the instructions of the manufacturer (NEB). These fragments were ligated into HincII- and CIP-treated pUC19. The clones were sequenced
to identify the cleavage sites.
DNA nicking activity from full-length and truncated
Nt.CviQII produced by cell-free transcription/translation
was assayed as follows: one microgram of pUC19 DNA
was incubated with 2 μl of the transcription/translation
product in NEB buffer 2 and 1 μg of bovine serum albumin (BSA) in a total volume of 20 μl at 30 °C for 4 h. Four
microliters samples were collected hourly and the reactions were stopped by adding 5 mM EDTA and 0.1%
SDS. Samples were analyzed on 0.8% agarose gels and
the intensities of the nicked DNA bands were quantified
by Quantity One software (Bio-Rad). The results from
two independent experiments were averaged and plotted
against time. Curve fitting was done using KaleidaGraph
(Synergy Software).
Identification of Nt.CviQII in NY-2A virions
Highly purified and protease K-treated PBCV-1 virions were solubilized and the virus proteins were separated by SDS–PAGE as described previously [11]. [Note:
Protease K at room temperature has no effect on PBCV-1
infectivity (Van Etten, unpublished results).] The gel was
stained with Sypro Ruby (Molecular Probes) and the revealed bands were excised. The proteins in the gel slices
were hydrolyzed by in-gel trypsin digestion [12]. The resulting peptide fragments were eluted from the gel pieces
and then analyzed using a Q-TOF Ultima tandem mass
spectrometer (Micromass/Waters) with electrospray ionization. The instrument was calibrated using the fragment
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ion masses of doubly protonated Glu-fibrinopeptide. The
MS/MS data were processed using Masslynx software
(Micromass) to produce peak lists for database searching.
MASCOT (Matrix Science) was used as the search engine.
Data were searched against the NY-2A non-redundant
database (Fitzgerald et al., manuscript in preparation).
Results
Cloning and identification of cviQIIM
Clones of cviQIIM were obtained by challenging a genomic library of NY-2A with MnlI [CCTC(7/6); GmAGG
sequences are not cleaved by MnlI]. M.CviQII was predicted to modify the adenine in RAG sequences. E.
coli cells containing plasmid DNA that express MTase
M.CviQII should be resistant to MnlI cleavage. Sequencing the plasmids from two MnlI partially resistant clones
led to the identification of a 269 codon ORF (Figure 1,
predicted molecular weight of 31 kDa) whose deduced
amino acid sequence indicates it is a m6A MTase [13].
In addition to motifs PXXGXG (motif I) and NPPF (motif IV) that are characteristic of m6A MTases (Figure 2),
M.CviQII also contains motifs II, III, V, VI, VIII, and X
that are shared by cytosine and adenine MTases. Furthermore, the linear order of the motifs, i.e. motif X followed
by I to VIII indicates that M.CviQII is a member of the γsubtype of m6A MTases (m6A γ MTase) [13].
Members of m6A γ MTases typically have relatively
low sequence identity to each other [13, 14]. For example, M.TaqI, M.HincII, M.EcoKI, M.SbfI, M.VspI, M.XmnI,
and M.PstI only share about 10% amino acid identity. Se-

quence identity is also low among some of the chlorella virus m6A γ MTases. M.CviBIII (from chlorella virus NC-1A)
and M.CviRI (from chlorella virus XZ-6E) only have 14%
and 11% amino acid sequence identity, respectively, with
M.CviQII. However, there is 35% amino acid sequence
identity between M.CviBIII and M.CviRI. Among all
known chlorella virus m6A MTases, M.CviQI (recognition
sequence GTAC), also from virus NY-2A [2], is most similar to M.CviQII with 24% amino acid sequence identity.
A BLAST search of GenBank (as of October 2005)
identified two putative m6A γ MTases from evolutionarily distant bacteria that resemble M.CviQII (Figure 2);
an unidentified ORF from Sphingopyxis alaskensis RB2256
(ZP_00579458) and a putative Type II MTase from Helicobacter pylori J99 (NP_223729) have 34% and 23% amino
acid sequence identity with M.CviXII, respectively. Like
M.CviQII, these two putative bacterial m6A γ MTases
lack motifs VII and IX, but contain all the other DNA
MTase motifs.
Alignment of M.CviQII and M.CviQI amino acid sequences with the two putative bacterial m6A γ MTases
revealed a conserved region between motifs VI and VIII
(Figure 2). This region, termed motif VII*, contains consensus AF residues that are flanked by charged and hydrophobic residues, respectively. Motif VII* could serve
the same function as motif VII which is involved in forming the catalytic region [15].
Identification of cviQIINt
Like bacteria, chlorella virus REase-encoding genes
are always located near their cognate DNA MTase gene,
although the spacing and relative orientation of the two

Figure 1. Gene organization of the CviQII N-M system. The MTase gene (cviQIIM) precedes the NEase gene (cviQIINt) in the same
orientation. The M.CviQII ORF spans nucleotides 495–1304 and encodes a protein of 269 amino acids, whereas the Nt.CviQII ORF
spans nucleotides 1301–2953 and encodes a protein of 550 amino acids. The first four nucleotides of cviQIINt (ATGA) overlap the
last four nucleotides of cviQIIM such that the cviQIINt translational start codon overlaps the cviQIIM stop codon. The C-terminal
deletion variants N528, N509, and N413 are diagrammed below the wt Nt.CviQII.
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Figure 2. Alignment of M.CviQII amino acid sequence to its closest matches from GenBank. ZP_00579458 and NP_223729 are putative ORFs from Sphingopyxis alaskensis RB2256 and Helicobacter pylori J99, respectively. M.CviQI is a γ-subtype of m6A MTase
isolated from chlorella virus NY-2A with a recognition sequence of GTmAC. DNA MTase motifs are underlined. Motif VII is absent in all four proteins; however, all four proteins have a similar amino acid sequence, labeled motif VII*. Identical residues are
shown in black boxes and conserved residues in MTase motifs are indicated by an asterisk.

genes can vary [14]. Therefore, we sequenced the NY-2A
genomic DNA adjacent to cviQIIM and identified an ORF
of 550 codons (Figure 1, in the same orientation as the
cviQIIM gene but in a different reading frame) that overlaps cviQIIM by four nucleotides. As a result, the stop codon of M.CviQII (ATGA) overlaps the Nt.CviQII start codon (ATGA). The Nt.CviQII ORF (predicted molecular
weight 63 kDa) has low sequence identity to all known
site-specific endonucleases except two from chlorella viruses. Nt.CviQII has 34% and 23% amino acid sequence
identity with Nt.CviPII and CviJI [CviJI short form, without the EEKKR repeats at the N-terminus, [16]], respectively (Figure 3). Nt.CviPII is a three-base NEase (↓CCD)
from chlorella virus NYs-1 [6], whereas, CviJI, from chlorella virus IL-3A, produces dsDNA breaks (RG ↓ CY) with

blunt ends [16] and [17]. There is one Type II endonuclease catalytic motif in Nt.CviQII, P237D238-X[25]–D264GK266
(Figure 3) [18]. This catalytic motif can be aligned to one
of the putative catalytic motifs of Nt.CviPII (A234E235-X[22]D258GK260) [6].
Nt.CviQII is at least 150 amino acids larger than all
other known chlorella virus site-specific endonucleases.
This increased length is due primarily to many tandem
repeats located between amino acids 414 and 485: 14 repeats of VKTP, 3 repeats of VKSP, 1 VLTP, and 1 VKIL
(Figure 3). Cell-free transcription/translation of a truncated mutant of Nt.CviQII indicates that the tandem repeat sequences are not required for DNA nicking activity
(see below). The biological role of the short amino acid repeats, if any, remained to be studied.
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Figure 3. Alignment of Nt.CviQII amino acid sequences with its closest matches in GenBank. Nt.CviPII (↓CCD) and CviJI
(RG ↓ CY) are from chlorella viruses NYs-1 and IL-3A, respectively. The putative active site residues in Nt.CviQII indicated by an
asterisk. The asterisks also indicates the putative active site residues of Nt.CviPII, which can be aligned to that of Nt.CviQII. Tandem repeats of VKTP are indicated. The terminal residues of truncation mutants NQN413, NQN509, and NQN528 are indicated
by arrows.

M.CviQII MTase activity
The genomic library of NY-2A was generated by ligating Sau3AI (↓ GATC) fragments of NY-2A genomic DNA
to BamHI (G↓ GATCC) cleaved pUCAC. Because there is
a Sau3AI site within the ORF of cviQIIM near the 5′ end,
the resulting pUCAC-cviQIIM clone generated a modified
form of M.CviQII such that the N-terminal 12 amino acid
residues of M.CviQII were replaced by the N-terminal 16
amino acid residues of LacZ α fragment. To determine if
bacterial DNA was methylated by this modified M.CviQII
in the transformed cells, total DNA (genomic and plasmid

pUCAC-cviQXIM DNAs) was isolated from the transformed cells and incubated with REases containing recognition sequences overlapping NAG: HindIII (A ↓ AGCTT)
and AflII (C ↓ TTAAG) for AAG; MnlI (↓N6GAGG) and
PleI (GAGTCN4↓) for GAG; PvuII (CAG ↓ CTG) for CAG
and XbaI (T ↓ CTAGA) for TAG; ScaI (AGT ↓ ACT) and
EcoNI (CCTNN ↓ NNNAGG) for NAG. Two REases,
DraI (CACNN ↓ GTG) and XmnI (GAANN ↓ NNTTC),
with unrelated recognition sequences were also tested
on the E. coli DNA as controls (Figure 4A). The DNA was
largely resistant to HindIII, AflII, MnlI, PleI, PvuII, XbaI,
ScaI, and EcoNI cleavage but not to DraI and XmnI. There-
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Figure 4. (A) In vivo protection of E. coli DNA by M.CviQII. Total DNA isolated from pUCAC-cviQII-transformed ER1992 was
challenged with REases with NAG recognition sequences (upper panel). The E. coli DNA, nicked, linearized, and supercoiled
forms of pUCAC-cviQIIM are indicated. The lower panel shows that the REases cleaved unmodified pUC19, pBR322, or φX174 dsDNA. (B) Purification of M.CviQII. The insoluble M.CviQII-intein-CBD fusion protein was refolded and intein-mediated cleavage
was induced by DTT. The protein solution was then loaded onto a SP column and eluted using a linear gradient of NaCl. The arrowhead indicates the band corresponds to M.CviQII on a 10–20% SDS–PAGE. (C) In vitro activity of M.CviQII. Substrate pUC19
DNA was incubated with or without M.CviQII in the presence of AdoMet followed by incubation with the indicated REases. Partial recognition sequences are shown on top of the corresponding REases. Substrate pUC19 DNA incubated with M.MspI, followed by MspI digestion, served as a control.

fore, M.CviQII modifies the adenine in AAG, GAG, CAG,
and TAG sequences, which means it methylates AG sequences. The presence of a small amount of linearized
plasmid DNA in the HindIII, MnlI, PleI, and PvuII reactions indicates that M.CviQII does not modify every AG
site in E. coli.
Full-length M.CviQII was also cloned and expressed
as a recombinant fusion protein. The cviQIIM gene was
ligated to pTXB1 to produce a C-terminal fusion protein
containing the Mxe GyrA intein and chitin-binding domain (CBD). However, the expressed fusion protein was
insoluble. After denaturing and refolding, the fusion protein was cleaved by the intein-mediated reaction and the
protein was purified by ion exchange chromatography
to 60% purity (Figure 4B). This partially purified pro-

tein was assayed for MTase activity using pUC19 DNA as
a substrate. After incubating pUC19 DNA with the partially purified M.CviQII and AdoMet, the DNA product
was incubated with appropriate REases to determine if
specific sites were protected (Figure 4C). Similar to the results of the in vivo experiments, M.CviQII partially protected AAG (against HindIII), GAG (against MnlI and
PleI), CAG (against PstI) and TAG (against XbaI) sites
from cleavage. These same REases cleaved control pUC19
into the expected fragments. MspI (C ↓ CGG) and PvuI
(CGAT ↓ CG), which are not inhibited by m6A, cleaved
the M.CviQII-modified pUC19 to completion. However,
like the in vivo methylation experiments, M.CviQII protection was not complete and both nicked and linearized
plasmid DNAs were observed in all of the reactions.
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Figure 5. (A) Intein-mediated peptide ligation. Truncated Nt.CviQII mutants NQN509 and NQN528 were ligated to peptides C42
and C23, respectively, by intein-mediated peptide ligation at 4 °C or 25 °C for 22 h. Ligated and unligated proteins are indicated.
(B) DNA nicking activity of the truncation mutants and ligated proteins incubated for various times at 30 °C. One microgram of
pUC19 DNA was incubated with 0.3 μg of the proteins and analyzed on a 1.5% agarose gel.

Cloning Nt.CviQII and construction of deletion mutants
The standard procedure for cloning R-M systems is
to protect the host DNA by expressing the MTase gene
before cloning the REase [19]. However, due to the high
number of Nt.CviQII nicking sites in the host genome,
cloning cviQIINt was expected to be difficult. We attempted to protect the host DNA by over-expressing
M.CviQII before introducing cviQIINt into E. coli. The
cviQIIM gene containing an optimal ribosome binding
site and spacing was ligated to pACYC184 or pLT7K [20]
because these two plasmids are compatible with the plasmids used to express cviQIINt. However, plasmid DNA
isolated from E. coli ER2566 transformed with these two
cviQIIM containing plasmids was only partially protected
against MnlI cleavage (data not shown).
Full-length cviQIINt was amplified from NY-2A genomic DNA by PCR and ligated into several plasmids including: (i) pR976 (vector constructed by P. Riggs, NEB),
a low copy plasmid with a Ptac promoter used to successfully clone Nt.CviPII [6] in the presence of pUCAC-cviQIIM, (ii) pLT7K in the presence of pACYC184-cviQIIM,
and (iii) a single-copy plasmid with inducible copy number that was derived from pBAC with a Ptac promoter
(pBACtac, unpublished results, J.C. Samuelson, NEB). All
attempts to clone cviQIINt into cviQIIM containing cells

were unsuccessful, either no inserts were obtained or the
inserts had altered cviQIINt sequences.
We then tried to express C-terminal truncation mutants of Nt.CviQII in E. coli and reconstruct the full-length
protein by ligating C-terminal peptide sequences to the
recombinant proteins using an intein-mediated peptide
ligation system (NEB). Two Nt.CviQII truncation mutants were constructed. The C-terminal 41 and 22 amino
acid residues were deleted in NQN509 (509 amino acids)
and NQN528 (528 amino acids), respectively (Figure 3).
Ser509 of NQN509 and Ser528 of NQN528 were mutated
to Cys to facilitate intein-mediated peptide ligation. The
two proteins were expressed as C-terminal fusions to intein Mxe GyrA followed by a CBD, which increased the
size of the recombinant truncated proteins by ~26 kDa.
The resulting constructs pTXB1-NQN509 and pTXB1NQN528 were expressed in E. coli ER2566. The expression
levels were relatively high and independent of the presence of the cviQIIM gene in the host cells. Proteins that
eluted from the chitin column were ligated to peptides
with an N-terminal Cys in the presence of reducing agent
(50 mM MESNA) at 4 °C and 25 °C. About 50% of the
truncated proteins were ligated to the peptides (Figure
5A). The ligated proteins were further purified by heparin column chromatography and assayed for DNA nicking activity.
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Figure 6. Purification and DNA nicking activity of truncation mutant NQN509. (A) The lysate supernatant from 2 L of expression
culture (In) was loaded onto a chitin column. After intein-mediated cleavage, the mutant protein was eluted (Ch). The eluted protein was diluted, and loaded onto a heparin column. The eluted protein was pooled (Hp) and dialyzed against potassium phosphate buffer. The dialyzed protein solution was loaded onto a hydroxyapatite column and the eluted protein was concentrated
and stored (Hy). The arrowhead indicates the band that corresponds to NQN509 on a 4–20% SDS–PAGE. (B) One hundred units
of the purified NQN509 were incubated with 1 μg of pUC19 at the indicated temperatures for 1 h. pUC19 linearized by NdeI or
without enzyme treatment served as controls for linearized and supercoiled DNA, respectively.

DNA nicking activity of Nt.CviQII and its truncation mutants
DNA nicking activity of the Nt.CviQII truncated mutants and reconstructed wild-type proteins were assayed
using the 2686 bp closed circular pUC19 DNA as a substrate; the two DNA strands of the plasmid contain 180
RAG sites. Complete cleavage of the plasmid should result in ssDNA fragments of ~50 nucleotides. One microgram (0.56 pmol) of pUC19 DNA was incubated with 4 μg
(60 pmol) of protein at 30 °C. All of the proteins exhibited
DNA nicking activity; however, none of them cleaved
pUC19 to 50 nucleotides in 1 h (Figure 5B). Therefore,
longer incubations were used. The ligated NQN509 + C42
protein had the highest DNA nicking activity in the first
2 h and its cleavage products became smaller with time
(Figure 5B). Both ligated and unligated NQN528 proteins
have similar activity. After incubating for 22 h, the cleavage products were 100–200 bp, indicating that the reaction did not go to completion. Incubating the cleavage
products with fresh NQN509 cleaved the DNA fragments
into smaller pieces, indicating that Nt.CviQII was inactivated during extended incubation before the cleavage reactions were completed (data not shown).

Since a stable cleavage pattern was not obtained in
2 h, one enzyme unit of Nt.CviQII and its deletion mutants was defined as the amount of protein needed to give
50% cleavage of 1 μg of closed-circular pUC19 DNAs to
a nicked circular form in 1 h. Using this definition, the
specific activities of NQN509 and NQN509 + C42 were
107,000 U/mg and 213,000 U/mg, respectively. The specific activities of NQN528 and NQN528 + C23 were both
80,000 U/mg (results not shown). The lower specific activities of NQN528 and its ligated protein may be due to
either altering protein conformation or the Ser528 to Cys
substitution.
Protein NQN509 was chosen for further study because
of its relatively high specific activity and it was easier to
produce. The chitin column fractions of NQN509 were
pooled and further purified through heparin and hydroxyapatite chromatography. A total of 15.6 mg of purified protein with 3 × 106 U were obtained (Table 1). The
purification is only 1.4-fold compared to the chitin column chromatograph because relatively high purity can
be obtained by the combination of chitin column and intein-mediated cleavage (Figure 6A). One hundred units of
purified NQN509 were incubated with 1 μg of pUC19 at

Table 1. Purification of NQN509
Steps
Lysate supernatant
Chitin column
Heparin
Hydroxyapatite
a
b

Total
proteina (mg)
350
29
20
15.6

Total
activitya (U)b
—
4.0 × 106
3.2 × 106
3.0 × 106

Specific
activity (U/mg)
—
138 × 103
160 × 103
192 × 103

Purification
Yield (%)
—
100
80
75

(fold)
—
1.0
1.2
1.4

The numbers are per Liter culture.
One enzyme unit is defined as the amount of enzyme needed to convert half of 1 μg of closed-circular form of pUC19 to nicked circular form.
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Figure 7. (A) DNA nicking activity of wt and truncation mutants of Nt.CviQII produced by cell-free transcription/translation.
ORFs of full-length wt, truncation mutants NQN528 (N528), NQN509 (N509), and NQN413 (N413) were amplified from NY-2A
genomic DNA in PCR. T7 promoter and a ribosome-binding sequence were added 5′ to the ORFs by appropriate primers. A PstI
ORF served as a positive control for the in vitro transcription/translation system. Cell-free transcription/translation products
were incubated with pUC19 DNA at 30 °C for 2 h. pUC19 DNA was cleaved by PstI and Nt.SapI to produce linearized and nicked
DNA, respectively. (B) Comparison of reaction rates of wt Nt.CviQII, NQN528, NQN509, and NQN413. The DNA nicking activity assay was continued for 4 h and the intensities of nicked and supercoiled DNA from two independent experiments were averaged. Fractions of nicked DNA were plotted against time and curve fitting was done using KaleidaGraph.

temperatures from 4 to 65 °C for 1 h (Figure 6B). The enzyme exhibited optimal activity at 16–25 °C with reduced
activity above 45 °C.
To compare the activity of the truncation mutants to
wt Nt.CviQII, a small quantity of wt enzyme was produced in a cell-free transcription/translation system, because we were unable to clone and express wt Nt.CviQII
in E. coli. Three Nt.CviQII truncation mutants were produced by the same system in parallel: NQN528, NQN509,
and NQN413 (with the last 137 codons deleted). The synthesized proteins contained a His-tag and their presence
in the resulting transcription/translation reaction was
confirmed by immuno-blotting using an anti-His-tag antibody (data not shown). NQN528 and NQN509 have similar reaction rates as wt Nt.CviQII over 4 h (Figure 7). Unexpectedly, NQN413 has a slightly higher initial rate than
the wt enzyme. Because NQN413 lacks the entire C-terminal tandem repeat sequences, we conclude that the
Nt.CviQII C-terminal 137 amino acids are not required
for DNA nicking activity.

Nt.CviQII nicking sites
To determine the Nt.CviQII cleavage sites, plasmid pBR322 was cleaved with dilutions of NQN509 and
NQN509 + C42 at 30 °C for 1 h. The cleaved fragments
were filled-in using the Klenow fragment and cloned into
pUC19. Sequencing the junctions of 10 cloned pBR322
fragments indicated that the two enzymes cleaved the
plasmid 5′ to the middle adenine at AAG or GAG sites
(data not shown). The length of the cleavage products
ranged from 60 to 300 bp with an average of 165 and
172 bp for NQN509 and NQN509 + C42, respectively
(data not shown). The 5′ end always started with AG and
the 3′ end always ended with CT (the reverse complement
of AG) in all the cloned fragments. These results indicate
that both NQN509 and NQN509 + C42 only cleaved plasmid DNA in one of the strands rather than both because
there would be a junction of TY … RA for staggered end
cleavage or Y … R for blunt end cleavage. Moreover, only
the RAG containing strand (not YTC) was cleaved. Oth-
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erwise, some fragments would end as TY … RA. The results agree with experiments reported previously where 2
RAG sites were sequenced [2].
Nt.CviQII is packaged in NY-2A virions
Attempts to identify all of the virus-encoded proteins
that are packaged in the NY-2A virion (Dunigan et al.,
manuscript in preparation) indicated that Nt.CviQII is
packaged in the virion, whereas its corresponding MTase
M.CviQII is not. The identified peptide fragments cover
32% of the Nt.CviQII protein with Mowse scores of high
confidence. One concern was that the enzyme might be a
contaminate protein on the surface of the virions. However, virions-treated with protease K during their purification did not remove Nt.CviQII. [Note: Most proteases have
little or no effect on PBCV-1 infectivity (Van Etten, unpublished results)]. These results suggest that Nt.CviQII has a
physiological function during an early phase of virus infection. Separate studies indicate that NY-2A infection causes
rapid degradation of host chlorella chromosomal DNA
(Agarkova et al., submitted for publication). Nt.CviQII
could be involved in this degradation process which may
aid in either shutting off host transcription during infection, allow for a recycling of nucleotides into virus progeny DNA, and/or prevent subsequent secondary virus infections by destroying the competing viral DNA.

Discussion
One unusual property of chlorella viruses is that they
encode multiple Type II DNA R-M systems [1, 21]. Virus NY-2A has the most heavily methylated DNA among
chlorella viruses (45% of the cytosines are m5C and 37%
of the adenines are m6A) and consequently its DNA is resistant to most REases [3]. In the current manuscript we
demonstrated that M.CviQII methylates AG sequences in
vitro and in vivo in a heterologous host (E. coli). Because
M.CviQII modifies a dinucleotide sequence, it can account for ~25% of the adenine methylation in NY-2A. To
our knowledge M.CviQII is the first m6A MTase to recognize a dinucleotide sequence. This property of M.CviQII
can be used to study the sensitivity of restriction endonucleases with overlapping AG sites.
After most of the experiments described in this manuscript were completed, the 370 kb NY-2A genome sequence became available (http://greengene.uml.edu).
Amazingly, NY-2A contains 18 putative MTase-encoding
genes (Table 1) (Fitzgerald et al., manuscript in preparation). In addition to the CviQII N-M system described in
this report, NY-2A encodes another R-M system, named
CviQI. CviQI is a typical Type II REase that cleaves 5′
of the T in G ↓ TAC sequences [2, 4]. Its cognate MTase
M.CviQI is also a m6A γ MTase that modifies adenine
in its recognition sequence. The cviQIR gene was cloned
and expressed in E. coli before the viral genome was sequenced (Zhu and Xu, unpublished results).
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Previously the methylation sites of eight other NY2A MTases were identified by either cloning the gene
(M.CviQIII, M.CviQV, M.CviQVI, and M.CviQVII) or deducing the site from the resistance of NY-2A DNA to selected REases (M.CviQIV, M.CviQVIII, M.CviQIX, and
M.CviQX) [2]. In fact, the M.CviQII methylation site was
inferred originally from the sensitivity/resistance of NY2A DNA to selected REases; the predicted site (RAR) was
nearly correct. Now knowing that NY-2A has 18 MTasesencoding genes, it is likely that the methylation site attributed to M.CviQII previously results from two or more
MTases with overlapping sequence specificities [2].
In addition to the CviQI R-M and CviQII N-M systems,
the 16 remaining MTases, which are located throughout
the NY-2A genome, may be orphan MTases because no
ORFs near these MTase-encoding genes resemble known
REases or NEases (Table 2) . The NY-2A gene number assigned to the 18 MTases, as well as their closest homologs from other chlorella viruses, are listed in Table 1.
Eleven of the 18 MTases are predicted to be m6A MTases
and seven are predicted to be m5C MTases. Of the 11
m6A MTases, seven are m6A γ MTases, three are m6A α
MTases, and one is a m6A β MTase. M.CviQXV resembles M.Hpy188I more than chlorella MTases.
Twelve of the 18 NY-2A MTases have >45% amino acid
identity with MTases from other chlorella viruses (Table 1). In particular, M.CviQVIII and M.CviQIV have 99%
and 89% amino acid identity to M.CviPI and M.CviPII,
respectively, from chlorella virus NYs-1 [2, 22]. The high
sequence identity among MTases from different viruses
suggests that the MTase genes have been shuffled among
the viruses during the course of evolution. Gene duplication within a virus, however, is not very common because
none of the NY-2A MTases have more than 50% amino
acid identity with each other.
Including the two site-specific endonucleases, at least
20 of NY-2A’s putative 400 protein-encoding genes (5%
of the genes) produce proteins involved in R/N-M functions; presumably they must serve some physiological
function(s). The Nt.CviQII enzyme is packaged in the virion and may be involved in degrading host chromosomal DNA, which occurs almost immediately after NY2A infection (Agarkova et al., submitted for publication).
However, other related viruses that infect the same chlorella host survive with fewer R-M encoding genes. For
example, the prototype chlorella virus, PBCV-1 has five
MTase-encoding genes, two of which have companion
REases (CviAI and CviAII) [1].
NY-2A not only encodes many putative genes involved
in R-M functions, it also has 28 putative homing endonuclease-encoding genes and six putative transposaseencoding genes (Fitzgerald et al., manuscript in preparation). Currently, it is not known if any of these genes
encode functional enzymes. Assuming that at least some
of these genes encode functional proteins, one might expect the NY-2A genome to be unstable. However, we have
grown NY-2A for about 20 years in the laboratory and
have not observed any evidence of genome instability.
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Table 2. DNA methyltransferases from virus NY-2A
Name
M.CviQIa

M.CviQIIa
M.CviQIIIa
M.CviQIVb
M.CviQVa
M.CviQVIa
M.CviQVIIa
M.CviQVIIIb
M.CviQIXb
M.CviQXc
M.CviQXIc
M.CviQXIIc
M.CviQXIIIc
M.CviQXIVc
M.CviQXVc
M.CviQXVIc
M.CviQXVIIc
M.CviQXVIIIc

NY-2A ORFd

Recognition sequence

Chlorella virus homologs

aa identity (%)

Type

B543L
B359R
B16L
B774R
B230L
B399R
B236L
B769R
B681L
B8R
B10R
B88L
B411L
B416R
B418R
B566R
B567L
B697R

GTmACa

—
—
M.CviBIII
M.CviAI
M.CviRI
M.CviBI
M.CviAII
M.CviPI
M.CviPII
—
—
M.CviAIII
M.CviPI
M.CviSI
—
—
M.CviSI
M.CviAIV

—
—
75
81
79
82
80
99
89
—
—
49
45
65
—
—
85
85

m6Aγ
m6Aγ
m6Aγ
m6Aα
m6Aγ
m6Aα
m6Aα
m5C
m5C
m5C
m6Aβ
m5C
m5C
m6Aγ
m6Aγe
m5C
m6Aγ
m5C

mAGa

TCGmAa
GmATCb
TGCmAa
GmANTCa
CmATGa
GmCb
mCCDb
mCGRb
—
—
GmCc
TGCmAc
TCNGmAe
—
TGCmAc
—

a

Proteins cloned and shown to have the indicated activity.
Recognition sequences deduced from the sensitivity/resistance of NY-2A DNA to selected REases.
c MTases are putative.
d The DNA sequences of the ORFs are available at http://greengene.uml.edu/.
e The recognition sequence and subtype of M.CviQXV are deduced from its homologous MTase M.Hpy188I, which shows 41% sequence identity with M.CviQXV.
b

Recombinant M.CviQII does not methylate every AG
sequence in substrate DNA in vitro because all eight
REases that are inhibited by m6A in AG sequences can
partially cleave M.CviQII-treated DNA. This lack of complete protection is unlikely to be due to sub-optimal reaction conditions (such as buffer composition or concentration of AdoMet) because permutations of various reaction
conditions did not improve the protection (results not
shown). Likewise, both plasmid and chromosomal DNAs
isolated from E. coli transformed with the cviQIIM gene
on high copy plasmids and controlled by a constitutive
lac promoter (pUCAC-cviQIIM) were only partially resistant to these same eight REases. However, NY-2A genomic DNA is completely resistant to Nt.CviQII. Therefore, either M.CviQII methylates all of the AG sites of the
virus DNA during virus replication in its natural hosts
(chlorella cells), or other NY-2A MTases methylate overlapping AG sites. For example, the recognition sequence
of M.CviQVI has been deduced to be GANTC [2].
Nt.CviQII is 150–200 amino acids larger than all the
other chlorella virus site-specific nucleases described to
date. This increased size is due primarily to a tetrapeptide
tandem repeat VKTP sequence located near the C-terminus (amino acids 414–485). A BLAST search of the repeat
sequence against proteins in GenBank revealed some similar, but not identical, tandem repeats in uncharacterized
ORFs from the fungus Gibberella zeae pH 1, the cellular
slime mold Dictyostelium discoideum, a putative ATP-dependent Acyl-CoA synthetase from protozoan Plasmodium
falciparum 3D7 and a hypothetical protein from chimpanzee Pan troglodytes.

The function of the Nt.CviQII tandem repeat is unknown. In vitro transcription/translation experiments established that it is not required for NEase activity because
Nt.CviQII truncation mutants have similar NEase activity as the full-length protein. However, after writing this
manuscript, a clone of full-length Nt.CviQII fused to the
intein and CBD was obtained after a few more attempts
of cloning. To our surprise, DNA nicking activity was
detected in the membrane fraction of the induced cells.
DNA nicking activity also occurred in the membrane fraction of the truncated mutants NQN509 and NQN528, albeit to a lesser extent. Finding the recombinant full-length
Nt.CviQII in the membrane fraction suggests that the Cterminal sequence (the tetrapeptide repeats and the proceeding sequence) may contribute to the membrane localization of the protein. Since mutants NQN509 and
NQN528 also have all of the tetrapeptide repeats, the Cterminal sequence may target the protein to the membrane. The tetrapeptide repeats could function to insert
the protein into the membrane. Additional mutagenesis
experiments will be conducted to explore this possibility.
Nt.CviQII is part of a short list of natural DNA nicking enzymes. It joins Nt.CviPII from chlorella virus NYs-1
in recognizing and nicking at very short recognition sites.
It is interesting that Nt.CviQII has 34% amino acid identity with Nt.CviPII even though they are sensitive to different methylated nucleotides, i.e. Nt.CviQII is blocked
by m6A and Nt.CviPII by m5C. Most REases and NEases
from chlorella viruses recognize and cleave short (3–5 bp)
recognition sequences (REBASE). Naturally occurring
nicking endonucleases from other organisms, such as
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Nt.BstNBI (GAGTCN4↓) [23], Nb.BsrDI(↓CATTGC) and
Nb.BtsI (↓CACTGC) from Bascillus sp. recognize and nick
5–6 bp recognition sequences (Xu and Zhu, unpublished
results). Other nicking endonucleases such as Nt.SapI
(GCTCTTCN↓) and Nt.AlwI (GGATCN4↓) have been created by genetically engineering known REases [24, 25].
The G + C content of the cviQIIM gene is 40%, that is
the same as the NY-2A genome. However, the G + C content of the cviQIINt gene is 36% and if the tandem repeats
are removed the G + C content is 33%. A similar phenomenon was observed with the CviPII N-M system in
which cviPIINt is 32% G + C and cviPIIM is 43% G + C. In
general, the G + C content of most chlorella virus genes
is about 40%. The relatively low GC contents of the two
NEase genes suggest that they might have been acquired
separately from their companion MTase genes.
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